{
  "id": 18154221,
  "title": "Darolutamide Improves Metastasis-Free Survival in Very High-Risk Prostate Cancer",
  "url": "https://urgent.news/2026/11/04/darolutamide-improves-metastasis-free-survival-in-very-high-risk",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-04T16:25:17.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/meetingcoverage/esmovideopearlsprostateca/123711"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- Adding darolutamide (Nubeqa) to androgen deprivation therapy (ADT) and radiation therapy significantly improved metastasis-free survival in patients with very high-risk prostate cancer, according to findings from the phase III...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}